Prime-Boost Vaccination With BNT162b2 Induces High Neutralizing Activity Against SARS-CoV-2 Variants in Naïve and COVID-19-Convalescent Individuals.

导出 LinkOut

翻译打印收藏纠错

作者： Joanna,Luczkowiak ^[1] ; Nuria,Labiod ^[1] ; Gonzalo,Rivas ^[2] ; Marta,Rolo ^[2] ; Fátima,Lasala ^[1] ; Jaime,Lora-Tamayo ^[3] ; Mikel,Mancheno-Losa ^[3] ; David,Rial ^[2] ; Alfredo,Pérez-Rivilla ^[2] ; María D,Folgueira ^[2] ; Rafael,Delgado ^[1]

作者单位： Instituto de Investigacion Hospital 12 de Octubre (imas12), Madrid, Spain. ^[1] Department of Microbiology, Hospital Universitario 12 de Octubre, Madrid, Spain. ^[2] Department of Internal Medicine, Hospital Universitario 12 de Octubre, Madrid, Spain. ^[3] School of Medicine, Universidad Complutense, Madrid, Spain. ^[4]

关键词 COVID-19 SARS-CoV-2 neutralizing antibodies vaccines variants of concern

DOI 10.1093/ofid/ofab468

PMID 34642637

发布时间 2023-11-07

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Open forum infectious diseases

2021年8卷10期

ofab468页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Prime-Boost Vaccination With BNT162b2 Induces High Neutralizing Activity Against SARS-CoV-2 Variants in Naïve and COVID-19-Convalescent Individuals.

Open forum infectious diseases

相似文献

Open forum infectious diseases

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Prime-Boost Vaccination With BNT162b2 Induces High Neutralizing Activity Against SARS-CoV-2 Variants in Naïve and COVID-19-Convalescent Individuals.

Open forum infectious diseases

相似文献

Open forum infectious diseases

相关期刊

检索历史清除